Is there a generic version of Anoro Ellipta yet?
No. Anoro Ellipta (umeclidinium + vilanterol) does not currently have an approved generic equivalent, so patients generally cannot get a true generic substitute through standard pharmacy generic substitution.
What does “generic” mean for inhalers like Anoro Ellipta?
Anoro Ellipta is a combination inhaler, pairing a long-acting muscarinic antagonist (umeclidinium) with a long-acting beta-agonist (vilanterol). For these combination dry-powder inhalers, a “generic” would require an approved product with comparable active ingredients, strength, and performance—often taking time even after patents and exclusivity narrow.
Are there alternatives even if there isn’t a generic?
Yes. Even without a generic, there may be other approved COPD maintenance inhalers with similar purposes (long-acting bronchodilation). These won’t be identical to Anoro, but they can be clinically comparable depending on a patient’s COPD pattern and prior therapy.
If you share your country (e.g., US, UK, Canada, etc.) and whether you need the exact Anoro ingredients (umeclidinium/vilanterol), I can narrow down the closest alternatives available there.
Where to check the latest approval/patent status
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can help confirm whether a generic or authorized alternative has entered. You can check Anoro Ellipta here: https://www.drugpatentwatch.com/